ZEB2 and renal cell carcinoma: By antagonizing miRNA-138, (targeting ADAM9), miRNA-204 (targeting CCND2), miRNA-217 (targeting genes like VEGFA, VIM, ZEB1 and ZEB2) and miRNA-200c (targeting ZEB1 and ZEB2), it results in collective interaction with RCC cell, proliferation, migration and invasion.115